2014 Bone Marrow Failure Disease Symposia - Penn State College of Medicine | Aplastic Anemia and MDS International Foundation

2014 Bone Marrow Failure Disease Symposia - Penn State College of Medicine

AA&MDSIF is co-sponsoring three symposia intended to provide updates on the most recent research related to the biology and clinical management of bone marrow failure diseases, including myelodysplastic syndromes, aplastic anemia, paroxysmal nocturnal hemoglobinuria, and myeloproliferative neoplasms. The overall goal of each continuing education symposium is to facilitate the translation of research findings into clinical practice and to improve the care of these patient populations.

At each event, local and national Hematology/Oncology experts will focus on the latest advances in the diagnosis, genetic characteristics, pathology, and treatment options for these diseases. The intended audience for the symposium includes hematologists, medical oncologists, internists, pathologists, residents/fellows, physician assistants, nurse practitioners, nurses, and allied health professionals treating patients with bone marrow failure diseases.

Penn State SymposiumPenn State College of Medicine

Saturday, September 27, 2014
8:00 am to 4:00 pm
The Hotel Hershey, 100 Hotel Road, Hershey, PA 17033

Agenda

8:00 – 8:30 am             Registration & Continental Breakfast
8:30 am – 4:00 pm       Program (lunch and breaks included)

Speakers:

  • Raymond J. Hohl, MD, Ph.D., Professor of Medicine and Director, Penn State Hershey Cancer Institute, Penn State University School of Medicine
    Title: Myelodysplastic Syndromes: Sixty and Maturing 
  • Richard W. Childs, MD, Clinical Director, Division of Intramural Research (DIR), National Heart, Lung, and Blood Institute (NHLBI)
    Title: Combined Transplantation with Umbilical Cord Blood and Haploidentical Stem Cells: A new and effective Treatment option for patients with Refractory Aplastic Anemia who lack HLA matched donors
  • Robert  A. Brodsky, MD, Director, Division of Hematology, Johns Hopkins Medicine Institute
    Title: PNH and Bone Marrow Failure
  • Michael G. Bayerl, MD, Associate professor, Department of Pathology, Penn State University School of Medicine
    Title: Pathologic Considerations in Bone Marrow Failure and Mimics
  • Thomas P. Loughran, MD, Professor of Medicine and Director, University of Virginia Cancer Center
    Title: Pathogenesis of LGL leukemia
  • Monica Bessler MD, PhD, Professor in Pediatrics and Internal Medicine
    Director, Pediatric & Adult Comprehensive Bone Marrow Failure Center
    The Children’s Hospital of Philadelphia and The Hospital of the University of Pennsylvania
    Title: Towards Precision Medicine in Bone Marrow Failure
  • David F. Claxton, MD, Professor of Medicine, Penn State Hershey Cancer Institute, Penn State University School of Medicine
    Title: Genomic Analysis and Advances in the treatment of Acute Myeloid Leukemia
  • Witold B. Rybka, MD, Professor and Director, Stem Cell Transplant Program
    Penn State Hershey Cancer Institute, Penn State University School of Medicine
    Title: Critical Conditions in Hematopoietic Cell Engraftment

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and the Aplastic Anemia & MDS International Foundation. Penn State College of Medicine is accredited by the ACCME to provide continuing education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credit(s) ™.